Background Image
Previous Page  18 / 36 Next Page
Basic version Information
Show Menu
Previous Page 18 / 36 Next Page
Page Background

18

The Lyme Times

Paul Lavoie, MD

By Suzanne Fratus

When I first met Paul Lavoie, I thought

he had to be a nut. How could a tick bite

30 years earlier still be causing such serious

health issues for me? Little did I know that

I had just met one of the most influential

persons in my life.

The first year and a half of treatments

was miserable. Each change of medication

knockedme down again and again. I almost

quit. Although those around me could see

definite improvement in my functioning,

I became discouraged and feared that my

quality of life might never again be worth

the effort I had to expend daily just to live.

Sure, after treatment I could get up from a

chair and walk down a flight of stairs on

my own. But when I compared where I was

with other 35-year old women, my life was

Paul Lavoie diagnosed the first case of

Lyme disease on the West Coast. A pioneer

physician, veteran pilot, amateur singer and

generous mentor, he died of pancreatic

cancer in 1993 at the age of 60.

JP Lavoie photo

FromThe Lyme Times #12, April 1994

Dr. Lavoie was a specialist in rheu-

matology and internal medicine in

private practice in San Francisco since

1973. He held several medical teaching

appointments, including Clinical

Professor of Medicine at UCSF. An

active board participant of national,

state, and local organizations, he was

a Founding Fellow of the American

Rheumatology Association.

In 1977, Dr. Lavoie diagnosed the

first two cases of Lyme disease in

the far-western United States. He

subsequently played a major role

in both the treatment and research

of Lyme disease, often bridging the

gap between the clinician and the

bio-medical community. He treated

hundreds of patients with Lyme

disease, and contributed 25 pub-

lished papers on aspects ranging from

laboratory diagnosis to clinical ap-

proaches. Lecturing widely, he par-

ticipated in special Lyme disease con-

ferences at both the NIH and CDC.

The Pioneers

still a train wreck.

I thanked Paul for his efforts and told

him that I was going to quit taking the

Lyme medication because I wasn't making

progress fast enough. I was sure that there

must be other disease processes going on.

Paul took time to explain

how the various medi-

cations could only in-

terfere with the bacteria

when it was replicating,

and since Lyme was a

very slow replicator it

took long than other

diseases. In the end he

left the decision up to me.

I decided to stick with

oral antibiotics - to give it

more time. That decision

saved my life.

Gradually, even I could

see there was undeniable

progress. In the meantime

I read everything I could

get my hands on about

Borellia

. Soon my

one hour appointment with Paul became

mini lessons in Lyme and other tick-borne

diseases. I was excited to exchanged names

and numbers with other patients in the

waiting room. I began to interview them

in depth about their health histories and

treatment plans..

"This can't all be Lyme disease." I said

to Paul. "There's more here," he told me as

he launched into a quick lecture on co-in-

fections.

Paul was getting heat from the local

rheumatologists and the pressure was on.

Suzanne Fratus, who has written her personal recollection of

Dr. Lavoie, seated with IGeneX president Nick Harris at a Lyme

conference in 2008.

as a Swiss student came back. [I said to

myself], “Willy, these are spirochetes!” The

slide showed long slender forms, a little bit

curved, and they were only in the mid-part

of the tick. Nowhere else. There were so

many people who said, “That is impossible

Willie. You can’t get spirochetes out of hard-

bodied ticks.” [But from my work on] re-

lapsing fever ticks from Africa, I knew what

a spirochete looked like. The Belgian Congo

and Kenya are hot spots for relapsing fever.

Even Livingston [the African explorer and

Scottish missionary] was exposed, and he

called it “tick fever.”

Willy says he remembered Hellerstrom’s

paper and couldn’t help thinking that he

had found “the long-sought causative agent

of

erythema migrans

and possibly also of

Lyme disease.”

Within weeks, Alan Barbour was cul-

turing the spirochetes, and European re-

searchers were looking for spirochetes in

European ticks. Spirochetes were found

in ticks in California and Oregon. There

are now over 10,000 publications on Lyme

disease listed on the National Library of

Medicine website. The spirochete was even-

tually named for the man who discovered it

though he has said he has never been sure if

he is happy about it.